Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Relapsing-Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells.
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.
Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes.
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
Network Analysis of Randomized Controlled Trials in Multiple Sclerosis.
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica.
Dendritic cells and multiple sclerosis: disease, tolerance and therapy.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
[Neuromyelitis optica and anti-aquaporin 4 antibody].
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil.
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis.
The role of diet in multiple sclerosis.
Differentiation of neurosphere-derived rat neural stem cells into oligodendrocyte-like cells by repressing PDGF-α and Olig2 with triiodothyronine.
Early recognition and diagnosis of multiple sclerosis.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.
Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis.
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.
Reverse causality behind the association between reproductive history and MS.
Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.
Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer's disease.
Pages
« first
‹ previous
…
257
258
259
260
261
262
263
264
265
…
next ›
last »